Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection
Launched by PARIS TRANSLATIONAL RESEARCH CENTER FOR ORGAN TRANSPLANTATION · May 24, 2024
Trial Information
Current as of March 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Living or deceased donor kidney recipient transplanted after 2004
- • Kidney recipient older than 18 years of age
- • Written informed consent at the time of transplantation for the center database
- Exclusion Criteria:
- • Combined transplantation
About Paris Translational Research Center For Organ Transplantation
The Paris Translational Research Center for Organ Transplantation is a leading clinical trial sponsor dedicated to advancing the field of organ transplantation through innovative research and collaborative efforts. Committed to bridging the gap between laboratory discoveries and clinical applications, the center focuses on improving transplant outcomes, enhancing patient care, and developing novel therapeutic strategies. With a multidisciplinary team of experts, the center fosters a rigorous research environment that promotes scientific excellence and ethical standards, ultimately aiming to transform the landscape of organ transplantation and provide hope for patients in need of lifesaving procedures.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Paris, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
